Do you want to read an article? Please log in or register.
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders
Multiple Sclerosis
RECOMMENDED
Related content
RECOMMENDED
Further Publications NeurologyFurther Publications Psychiatry
Brain and cord imaging features in neuromyelitis optica spectrum disorders
Ann Neurol.
Cacciaguerra L, Meani A, Mesaros S, Radaelli M, Palace J, Dujmovic-Basuroski I, Pagani E, Martinelli V, Matthews L, Drulovic J, Leite MI, Comi G, Filippi M, Rocca MA
doi: 10.1002/ana.25411.
RECOMMENDED
Multiple Sclerosis
Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
J Neurol.
Ellrichmann G, Bolz J, Peschke M, Duscha A, Hellwig K, Lee DH, Linker RA, Gold R, Haghikia A
doi: 10.1007/s00415-018-9092-4.
Multiple Sclerosis
Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis
Brain
Mariano R, Messina S, Roca-Fernandez A, Leite MI, Kong Y, Palace JA
doi: 10.1093/brain/awaa347
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
J Neurol Neurosurg Psychiatry.
Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, Pache F, Ruprecht K, Havla J, Kümpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Young KL, Schuster S, Stangel M, Lauda F, Tumani H, Mayer C, Zeltner L, Ziemann U, Linker RA, Schwab M, Marziniak M, Then Bergh F, Hofstadt-van Oy U, Neuhaus O, Zettl U, Faiss J, Wildemann B, Paul F, Jarius S, Trebst C, Kleiter I; NEMOS (Neuromyelitis Optica Study Group)
doi: 10.1136/jnnp-2017-315603.
RECOMMENDED
Further Publications NeurologyFurther Publications Psychiatry
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
N Engl J Med.
Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, Nakashima I, Terzi M, Totolyan N, Viswanathan S, Wang KC, Pace A, Fujita KP, Armstrong R, Wingerchuk DM
doi: 10.1056/NEJMoa1900866.
Multiple Sclerosis
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Brain
Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J
doi: 10.1093/brain/awy154.
RECOMMENDED
Multiple Sclerosis
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
doi: 10.1016/S1474-4422(20)30070-3.
RECOMMENDED
Multiple Sclerosis
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
N Engl J Med.
Yamamura T, Kleiter I, Fujihara K, Palace J, Greenberg B, Zakrzewska-Pniewska B, Patti F, Tsai CP, Saiz A, Yamazaki H, Kawata Y, Wright P, De Seze J
doi: 10.1056/NEJMoa1901747.
Multiple Sclerosis
Spinal cord volume loss: A marker of disease progression in multiple sclerosis
Neurology.
Tsagkas C, Magon S, Gaetano L, Pezold S, Naegelin Y, Amann M, Stippich C, Cattin P, Wuerfel J, Bieri O, Sprenger T, Kappos L, Parmar K
doi: 10.1212/